[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100434901":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":21,"centralContacts":26,"locations":33,"responsibleParty":50,"collaborators":53,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":31,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":35,"whyStopped":31,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Institute of Mother and Child, Warsaw, Poland","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"R1 low intervention arm","Children of both sexes who meet all inclusion criteria and do not meet any exclusion criteria will be eligible for the study.",[12],"Drug: fluorodeoxyglucose (18F-FDG)",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","fluorodeoxyglucose (18F-FDG)","max 6 MGBq\u002Fkg, no more than 100",[9],[20],"GLUNEKTIK; SYNEKTIK",[22],{"name":23,"affiliation":24,"role":25},"Anna Raciborska","Mother and Child Institute","PRINCIPAL_INVESTIGATOR",[27],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},"Katarzyna Maleszewska","CONTACT","+48 22 32 77 205",null,"klinika.onkologii@imid.med.pl",[34],{"facility":24,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Warsaw","Mazovian","01-211","Poland","PL",{"type":42,"coordinates":43},"Point",[44,45],21.01178,52.22977,{"lat":45,"lon":44},[48,49],{"name":28,"role":29,"phone":30,"phoneExt":31,"email":32},{"name":23,"role":25,"phone":31,"phoneExt":31,"email":31},{"type":51,"investigatorFullName":23,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"SPONSOR_INVESTIGATOR","Prof Ass",[54,56,59],{"name":55,"class":6},"Maria Sklodowska-Curie National Research Institute of Oncology",{"name":57,"class":58},"Łukasiewicz Research Network","UNKNOWN",{"name":60,"class":6},"Wroclaw University of Environmental and Life Sciences","100434901","phase-3-determination-of-molecular-status-the-efficacy-and-safety-of-fluorodeoxyglucose-in-pet-ct-imaging-100434901",false,"NCT04943211","Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT Imaging","Determination of Molecular Status, as Well as the Efficacy and Safety of Fluorodeoxyglucose (18F-FDG) in PET-CT Imaging in Juvenile Patients With Histiocytosis","HISTIOGEN","Inclusion Criteria:\n\n1. Patient under 18 years of age at the time of inclusion.\n2. Histopathologically confirmed or suspected histiocytosis (based on prior test results).\n3. Signing of informed consent for trial participation according with current legal regulations.\n\nExclusion Criteria:\n\n1. Lack of inclusion criteria.\n2. Pregnancy.\n3. Other acute or persistent disorders, behaviors or abnormal laboratory test results, which might increase the risk related to the participation in this clinical trial or to taking the study drug, or which might influence the interpretation of the study results, or which, in the investigator's opinion, disqualify a patient from participating in the trial.","ALL","1 Year","18 Years",{"count":73,"type":74},150,"ESTIMATED","INTERVENTIONAL",[77],"PHASE3","Prospective, low intervention, open, single-center, non-commercial clinical trial to improve diagnostics in patients with histiocytosis by assessing the molecular profile of the tumor tissues, monitoring its presence in free-circulating DNA, and determining the efficacy of fluorodeoxyglucose (18F-FDG) in PET-CT imaging.",[80],"Histiocytosis",[82,83,84,85,86],"Langerhans cell histiocytosis (LCH)","histiocytosis","Positron Emission Tomography (PET)","molecular status","paediatric patients","2026-03-24",{"date":89,"type":90},"2026-03-25","ACTUAL",{"date":92,"type":90},"2021-04-01",{"date":94,"type":74},"2027-06-30",{"name":23,"class":6},1]